Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Highlands Oncology Group | Researchclopedia

Back to institutions

Highlands Oncology Group

Fayetteville, Arkansashealthcare

387

Works

19,473

Citations

65

h-index

Top Research Topics

Advanced Breast Cancer Therapies Lung Cancer Research Studies Lung Cancer Treatments and Mutations

Top Researchers

Gabriel N. Hortobágyi The University of Texas MD Anderson Cancer Center

1,905 works139,599 citationsh-index: 187

Recent Research

Role of Surface Termination in the Structural and Electronic Properties of Sc$$_2$$CT$$_\textrm{x}$$ MXene

Da’Shawn M. Morris,Ashna Upreti,et al.

20260 citations

HER2/EGFR in Cancer Research

Cancer Treatment and Pharmacology

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

Breast Cancer Treatment Studies

Chronic Lymphocytic Leukemia Research

Cancer Genomics and Diagnostics

PI3K/AKT/mTOR signaling in cancer

PARP inhibition in cancer therapy

José Baselga Hebron University

1,379 works117,695 citationsh-index: 143

Nadia Harbeck Deutsches Archäologisches Institut, Zentrale

2,055 works85,117 citationsh-index: 131

Javier Cortés Villa Maria Hospital

1,474 works67,750 citationsh-index: 113

Edith A. Perez Jacksonville College

663 works58,980 citationsh-index: 95

Mario Campone Institut de Cancérologie de l'Ouest

1,061 works52,520 citationsh-index: 93

Abstract PS1-05-04: A multi-practice quality initiative evaluating antiemetic use in metastatic breast cancer patients treated with trastuzumab deruxtecan-nxki (T-DXd)

S. Rosenfeld,Olalekan Ajayi,et al.

20260 citations

Abstract PS1-10-27: Progression-free survival (PFS) and overall survival (OS) results from the phase 3 MONALEESA-3 trial of postmenopausal patients with hormone receptor-positive (HR+)/HER2-negative (HER2−) advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL): A subgroup analysis of patients with invasive lobular carcinoma (ILC)

M. De Laurentiis,Jason Mouabbi,et al.

20260 citations

Abstract PS1-11-17: Real-world comparison of time to next treatment for patients with HR-positive, HER2-low metastatic breast cancer treated with either chemotherapy or trastuzumab deruxtecan in the second-line

R. L. Mahtani,Rushir J. Choksi,et al.

20260 citations

Abstract PS5-03-12: Real-world BRCA and PD-L1 testing among first-line triple negative metastatic breast cancer patients

Fred J. Kudrik,Rushir J. Choksi,et al.

20260 citations

Abstract RF7-01: Elacestrant in combination with everolimus or abemaciclib in patients with ER+/HER2- locally advanced or metastatic breast cancer (mBC): phase 2 results from ELEVATE, an open-label, umbrella study

H. S. Rugo,S. M. Tolaney,et al.

20260 citations